Yosprala
Product Images NDC 70347-325

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Yosprala (NDC 70347-325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aralez Pharmaceuticals Us Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottles Of 30 Tablets (325-40)

Label for Yosprala delayed-release tablets, containing 325 mg aspirin and 40 mg omeprazole. The label indicates a package size of 30 tablets, with dosing instructions to take one tablet daily at least 60 minutes before a meal. The labeler is Aralez Pharmaceuticals US Inc., Princeton, NJ, with storage recommendations and a barcode included.*

FDA Label Image

Bottles Of 30 Tablets (81-40)

Yosprala tablets containing 81 mg aspirin delayed-release and 40 mg omeprazole immediate-release. The label indicates a 30-tablet count and advises dispensing with an accompanying medication guide. Manufactured for Aralez Pharmaceuticals US Inc., storage instructions and usage directions are partially visible.*

FDA Label Image

Bottles Of 90 Tablets (325-40)

Label of Yosprala delayed-release tablets containing 325 mg aspirin and 40 mg omeprazole, provided in a bottle of 90 tablets by Aralez Pharmaceuticals US Inc. The label lists storage instructions and usage precautions, including not splitting or crushing the tablets, and mentions it is Rx only.*

FDA Label Image

Bottles Of 90 Tablets 81-40 (90tablets)

Yosprala 81 mg/40 mg delayed-release tablets label displaying aspirin and omeprazole as active ingredients. The label includes directions to take one tablet daily before a meal, storage instructions to keep the bottle tightly closed and store at 25°C, and a package count of 90 tablets. Manufactured by Aralez Pharmaceuticals US Inc., the label also notes the Rx only status and cautions not to split, chew, crush, or dissolve the tablet.*

FDA Label Image

Aspirin (Yosprala 01)

Chemical structure of the active ingredient shown in the image, featuring a benzene ring bonded to a carboxylic acid group and an acetoxy group.*

FDA Label Image

Omeprazole (Yosprala 02)

Chemical structure diagram of the active ingredient(s) in YOSPRALA, showing detailed molecular connectivity including aromatic rings, nitrogen, oxygen, sulfur atoms, and methyl and methoxy groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.